Elevated plasma TGF-β 1 levels correlate with decreased survival of metastatic breast cancer patients

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 191-193

  Ivanović, Vesna ^a   Demajo, Miroslav ^a   Krtolica, Koviljka ^a   Krajnović, Milena ^a   Konstantinović, Miroslav ^b   Baltić, Vladimir ^c   Prtenjak, Gordana ^c   Stojiljković, Bratislav ^c   Breberina, Milan ^c   Nes ̌ković Konstantinović, Zora ^d   Nikolić Vukosavljević, Dragica ^d   Dimitrijević, Bogomir ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^c Institute for Oncology   (Serbia)

^d INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Breast cancer prognosis; Plasma TGF 1; Survival

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

BREAST CANCER; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; METASTASIS; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 33746701947     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.027     Document Type: Letter

References (8)

1. Esteva F.J., and Hortobagyi G.N. Prognostic molecular markers in early breast cancer. Breast Cancer Res 6 (2004) 109-118
2. Elliott R.L., and Blobe G.C. Role of transforming growth factor beta in human cancer. J Clin Oncol 23 (2005) 2078-2093
3. Friess H., Yamanaka Y., Buchler M., et al. Enhanced expression of TGF-β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105 (1993) 1846-1856
4. 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 74 (1996) 753-758
5. 1 ) in patients with advanced breast cancer: association with disease progression. Eur J Cancer 39 (2003) 454-461
6. 1 and second primary breast cancer in a chemoprevention trial. Eur J Cancer 34 (1998) 999-1003
7. Kong F.M., Anscher M.S., Murase T., Abbott B.D., Iglehart J.D., and Jirtle R.L. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg 222 (1995) 155-162
8. Collett D. Modeling Survival Data in Medical Research (1994), Chapman & Hall, London